rs151170797

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_025009.5(CEP135):​c.2755A>C​(p.Arg919Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.00197 in 1,584,730 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 5 hom. )

Consequence

CEP135
NM_025009.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.59

Publications

1 publications found
Variant links:
Genes affected
CEP135 (HGNC:29086): (centrosomal protein 135) This gene encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in this gene are associated with autosomal recessive primary microcephaly-8. [provided by RefSeq, Jun 2012]
CEP135 Gene-Disease associations (from GenCC):
  • microcephaly 8, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 4-56011938-A-C is Benign according to our data. Variant chr4-56011938-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00194 (296/152370) while in subpopulation NFE AF = 0.00244 (166/68042). AF 95% confidence interval is 0.00214. There are 2 homozygotes in GnomAd4. There are 157 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP135NM_025009.5 linkc.2755A>C p.Arg919Arg synonymous_variant Exon 21 of 26 ENST00000257287.5 NP_079285.2 Q66GS9-1
CEP135XM_006714055.4 linkc.2722A>C p.Arg908Arg synonymous_variant Exon 21 of 26 XP_006714118.1
CEP135XM_005265788.5 linkc.1684A>C p.Arg562Arg synonymous_variant Exon 14 of 19 XP_005265845.1
CEP135XM_011534412.2 linkc.1225A>C p.Arg409Arg synonymous_variant Exon 11 of 16 XP_011532714.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP135ENST00000257287.5 linkc.2755A>C p.Arg919Arg synonymous_variant Exon 21 of 26 1 NM_025009.5 ENSP00000257287.3 Q66GS9-1
CEP135ENST00000506202.1 linkn.2705A>C non_coding_transcript_exon_variant Exon 14 of 19 1
CEP135ENST00000706801.1 linkn.820A>C non_coding_transcript_exon_variant Exon 5 of 10

Frequencies

GnomAD3 genomes
AF:
0.00194
AC:
296
AN:
152252
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00772
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00244
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00186
AC:
419
AN:
225278
AF XY:
0.00188
show subpopulations
Gnomad AFR exome
AF:
0.000338
Gnomad AMR exome
AF:
0.00140
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00654
Gnomad NFE exome
AF:
0.00208
Gnomad OTH exome
AF:
0.00170
GnomAD4 exome
AF:
0.00197
AC:
2827
AN:
1432360
Hom.:
5
Cov.:
31
AF XY:
0.00197
AC XY:
1400
AN XY:
712140
show subpopulations
African (AFR)
AF:
0.000157
AC:
5
AN:
31776
American (AMR)
AF:
0.00133
AC:
52
AN:
39222
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25178
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38330
South Asian (SAS)
AF:
0.000297
AC:
24
AN:
80758
European-Finnish (FIN)
AF:
0.00568
AC:
300
AN:
52856
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5624
European-Non Finnish (NFE)
AF:
0.00216
AC:
2376
AN:
1099586
Other (OTH)
AF:
0.00117
AC:
69
AN:
59030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
127
255
382
510
637
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00194
AC:
296
AN:
152370
Hom.:
2
Cov.:
32
AF XY:
0.00211
AC XY:
157
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41590
American (AMR)
AF:
0.00111
AC:
17
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00772
AC:
82
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00244
AC:
166
AN:
68042
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
0
Bravo
AF:
0.00136
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 30, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEP135: BP4, BS2 -

not specified Benign:1
Sep 27, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
11
DANN
Benign
0.69
PhyloP100
6.6
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151170797; hg19: chr4-56878104; API